GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Chattem, Inc. (CHTT) [hlAlert]

Rating:
Outperform
CHTT
up 43.75 %

Chattem, Inc. (CHTT) rated Outperform with price target $80 by Oppenheimer

Posted on: Wednesday,  Feb 11, 2009  8:25 AM ET by Oppenheimer

Oppenheimer rated Outperform Chattem, Inc. (NASDAQ: CHTT) on 02/11/2009, when the stock price was $64.90. Since
then, Chattem, Inc. has gained 43.76% as of 03/10/2010's recent price of $93.30.
If you would have followed this Oppenheimer's recommendation on CHTT, you would have gained 43.75% of your investment in 392 days.

Chattem, Inc. is a leading marketer and manufacturer of a variety of branded consumer products, including over-the-counter health care and toiletries and skin care products. The company's high quality brandedproducts target niche market segments and are among the market leaders in their respective categories. Through creative and cost effective marketing techniques, these brands on a national level across all major distributionchannels, including food, drug and mass merchandisers.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/11/2009 8:25 AM Buy
None
64.90 80.00
as of 12/31/2009
1 Week up  0.25 %
1 Month up  41.99 %
3 Months up  40.77 %
1 YTD up  44.05 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy